Cost and Insurance Coverage

Esketamine insurance coverage is common but not automatic. Spravato, the brand name for esketamine nasal spray, is FDA-approved for certain adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. Commercial plans and Medicare may cover it when their clinical and prior-authorization requirements are met. By contrast, racemic ketamine for depression is generally prescribed off label, so patients often pay out of pocket.

Your actual cost depends on the medication route, diagnosis, insurer, treatment setting, deductible, copay or coinsurance, and required monitoring. Ask both the prescribing clinic and your insurer for a written estimate before beginning care.

Does insurance cover esketamine?

Insurance may cover esketamine, but each plan sets its own medical-necessity criteria. Many insurers request documentation of treatment-resistant depression, previous antidepressant treatment, psychiatric evaluation, and a plan for supervised administration. Some plans may require trials of specific oral antidepressants, while others use different criteria. Do not assume that a reported requirement, such as failure of two oral antidepressants, applies to every policy.

Spravato must be administered in a certified healthcare setting under the Spravato REMS program, with monitoring after each dose. That setting and observation requirement can affect billing as well as scheduling. The FDA-approved prescribing information explains the approved uses, dosing, and monitoring requirements.

According to the FDA prescribing information for Spravato, the usual induction schedule for treatment-resistant depression is twice weekly for the first four weeks, which equals up to eight treatment visits before the frequency changes.

Medicare coverage also requires confirmation. Medicare Part B can cover certain drugs administered in an outpatient setting, but coverage and patient responsibility can depend on the provider, billing arrangement, and whether Medicare requirements are met. Review Medicare's outpatient prescription drug coverage information and contact your plan or clinic for a patient-specific answer.

Does insurance cover racemic ketamine?

Racemic ketamine is an older anesthetic medication. When used for depression, it is generally prescribed off label because the FDA has not approved racemic ketamine specifically for depression. That distinction often makes insurance coverage difficult, even when a clinician believes treatment is appropriate.

Some plans may reimburse part of a related service, such as an evaluation or facility charge, while declining to cover the medication or infusion itself. Coverage decisions differ by policy and provider, so request billing codes and an itemized estimate rather than relying on a general statement that ketamine is or is not covered.

If you are considering treatment because standard options have not helped, review next steps for treatment-resistant depression with a qualified mental health professional. This can help you understand where ketamine-based treatment fits among other options.

What does ketamine treatment cost without insurance?

Self-pay prices vary substantially by geography, clinician involvement, monitoring, and the number of sessions recommended. Published clinic pricing often places IV racemic ketamine infusions around $400-$1,200 per session and intramuscular injections around $250-$500 per session. A six-session IV series at those prices would be about $2,400-$7,200 before any additional clinical fees.

At-home sublingual or oral programs are often advertised in the range of $200-$500 per month, although this may or may not include evaluation, medication, follow-up visits, shipping, or psychotherapy. Esketamine's medication price before insurance is also separate from the clinical setting and required observation. Treat any advertised price as a starting point, not a complete treatment estimate.

Frequency matters as much as the per-session price. See how many ketamine treatments may be recommended and how treatment spacing can vary for questions to discuss with a clinician.

What to ask your insurer and provider

Use specific questions. Ask your insurer whether Spravato is covered for your diagnosis, whether prior authorization is required, which records are needed, and whether the clinic is in network. Ask the provider for the drug name, treatment route, expected number of visits, CPT or billing codes if available, and a written estimate that separates medication from professional, facility, monitoring, and follow-up charges.

Also ask what happens if authorization is denied. The clinic may be able to explain an appeal process or discuss other clinically appropriate options, but no provider can promise approval. If you use other medications or substances, bring that information to your prescriber because it can affect safety planning. Our guide to ketamine drug interactions covers common discussion points.